Prime Medicine, Inc. · NASDAQ:PRME
T. Rowe Price Investment Management, Inc.'s stake in Prime Medicine, Inc. fell to 3.30% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
T. Rowe Price Investment Management, Inc.'s stake in Prime Medicine, Inc. fell to 3.30%, 5,995,183 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 3.30%
- Shares
- 5,995,183
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 3.30% | 5,995,183 |
Source
Related
- Prime Medicine, Inc.
- T. Rowe Price Investment Management, Inc.
- Prime Medicine, Inc. shareholders
- Schedule 13G · T. Rowe Price Investment Management, Inc. · Nov 14, 2025
- Schedule 13G/A · Alphabet Holdings LLC · Nov 12, 2025
- Schedule 13G/A · FMR LLC · Nov 5, 2025
- Schedule 13D/A · ARCH Venture Fund X, L.P. · Aug 11, 2025
- Schedule 13G/A · Newpath Partners, L.P. · Feb 14, 2025